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Summary
Objective: The extracellular matrix glycoprotein tenascin (TN) is upregulated in articular cartilage with severe osteoarthritis (OA). This study
gives a detailed description of TN expression in areas of articular cartilage from femoral heads with mild OA showing structural lesions and
in structurally normal areas of the same femoral heads compared with normal cartilage and cartilage with severe OA.
Methods: Immunohistochemical evaluation was performed on cryosections stained with antibodies against TN. Sections were selected as
follows: from each macroscopically normal femoral head (n6) a normal central and peripheral biopsy; from each femoral head with
macroscopically mild OA (n8) a central biopsy that showed structural lesions and a peripheral normal biopsy; from each femoral head with
severe OA (n9) a central and a peripheral biopsy with structural lesions. Central biopsies represent load bearing areas, whereas peripheral
biopsies are non-load bearing.
Results: Central cartilage with mild OA contains significantly higher levels of TN in the superficial zone than structurally normal, peripheral
cartilage from the same femoral heads. Normal cartilage and cartilage with severe OA do not display this topographic variation. Central
cartilage with mild OA shows significantly higher levels of TN than normal, central cartilage. Peripheral, normal cartilage with mild OA shows
significantly less TN than peripheral cartilage with severe OA.
Conclusions: In femoral heads with mild OA, TN is accumulated in areas displaying structural damage. This proposes mild OA to be a
localized disorder. Extreme caution is necessary for sampling of articular cartilage, especially from joints with mild OA.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Science Ltd. All rights reserved.
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Introduction
In joints with severe osteoarthritis (OA) the entire articu-
lating surface is damaged, manifested by disorganization
and erosion of articular cartilage. In cases of less severe
OA, the lesions include only localized areas of cartilage
damage, at least at the macroscopical level1.
The extracellular matrix glycoprotein tenascin (TN) is
involved in embryogenesis and wound healing, presumably
through modification of the cellular adhesion to fibronectin
(Fn)2. TN is highly expressed in human articular cartilage in
relation to structural damage, as fibrillated and fissured
areas of articular cartilage with severe OA are known to
accumulate TN3.
Several studies have documented elevated levels of TN
in cartilage and synovial fluid from individuals suffering from
severe OA3,4. Recently, TN was shown to be the most
promising molecular marker of cartilage degradation in
synovial fluid from patients suffering from severe OA of the
knee, whereas the initial stages of OA did not present
increased levels of TN5. TN is also increased in serum from
patients suffering from severe OA, hence TN has been
proposed as a marker of OA6. In a rabbit model of OA, TN
has been shown to be increased in the superficial zone of
femoral condylar cartilage with moderate and severe OA7.
However, the distribution of TN has not been detailed in
human articular cartilage with mild OA or in macro- and
microscopically normal areas of cartilage from femoral
heads with mild OA.
The objective of this study was to detail the expression of
TN in load bearing areas of articular cartilage from femoral
heads with mild OA showing structural lesions and in
structurally normal non-load bearing areas of the same
femoral heads compared with normal cartilage and
cartilage with severe OA.
Methods
SAMPLING OF ARTICULAR CARTILAGE
Normal cartilage and cartilage with mild OA were
obtained from the femoral head at autopsy. Biopsies
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representing severe OA were obtained from patients under-
going hip replacement surgery due to OA. None of the
patients had a history of a systemic inflammatory disease.
The femoral heads were graded macroscopically according
to Collins/McElligot8, and the location and nature of any
pathological alterations were noted. Grade 0 femoral heads
correspond to normal cartilage, whereas grades 1 and 2
correspond to mild OA. Grades 3 and 4 with areas of
denuded bone correspond to severe OA (Table I).
Sampling of biopsies covering all aspects of the femoral
head was performed in a standardized way, as described
by Ostergaard and Salter9. In brief, biopsies anterior,
posterior, medial, and lateral to fovea capitis femoris
(perifoveal), next to the insertion of the articular capsule
(peripheral), and in between (intermediate) (12 biopsies
in total) were sampled from each femoral head and stored
at −80°C. In the following, perifoveal and intermediate
biopsies together are referred to as central biopsies.
After macroscopical grading, histopathological evalu-
ation was performed to choose the desired biopsies—from
each grade 0 femoral head a central and a peripheral
biopsy that showed no structural changes; from each grade
1 and 2 femoral head, a central sampling site showing
pathological features of OA at the macroscopic level, a
biopsy that showed fibrillation or fissures in the superficial
zone (located lateral intermediate or posterior perifoveal),
and a peripheral biopsy that did not show any structural
change at either the macroscopical or the histological level;
from each grade 3 and 4 femoral head a central and a
peripheral biopsy displaying severe structural changes (i.e.
fibrillation and clefts). In five cases of severe OA no
peripheral biopsy could be obtained. In total 49 biopsies
were selected. Two central biopsies from normal femoral
heads and one central biopsy from a femoral head with
severe OA could not be evaluated due to either floating off
or extensive folding of the section. Forty-six sections were
suitable for immunohistochemical evaluation.
HISTO- AND IMMUNOHISTOCHEMICAL PROCESSING
Five micrometer cryosections were mounted on
SuperFrost/Plus glass slides (Eire Scientific, Portsmouth,
NH, USA). Sections for histochemistry were fixed in for-
malin for 24 h, while sections for immunohistochemistry
(IHC) were fixed in acetone for 15 min at room temperature
as described inreference 10. All stainings were performed
using a Shandon Sequenza.
Stainings were performed with Weigert’s acid iron
chloride haematoxylin for 6 min, Fast Green for 3 min, and
safranin-O for 5 min (SFH stainings). The first wash was
with tap water, the second with 1% acetic acid, and the
two washes following safranin-O were with 96 and 100%
alcohol, respectively.
The IHC procedure has been described previously11. In
brief, 100 µl of the primary antibody was applied diluted to
optimal concentration in Tris-buffered saline (TBS). The
concentration of the monoclonal anti-TN antibody (clone
TN2, DAKO, Glostrup, Denmark) was 0.654 µg/ml. The
antibody recognizes all TN isoforms. The primary antibody
was incubated for 24 h at 4°C in a humidified chamber. The
following incubations were performed at room temperature
and 100 µl of each solution was added (all supplied by
DAKO). The specimens were washed twice with 2 ml of
TBS, and incubated for 25 min with a biotinylated rabbit
anti-mouse secondary antibody. The washing procedure
was repeated and endogenous peroxidase activity was
blocked by incubation for 8 min with 3% H2O2. Horseradish
Table I
Cases studied
Macroscopical grading No. of cases (sex) Median age (range) Source
Normal 8 (6M, 2F) 59.5 (32–77) Autopsy
Mild OA 10 (5M, 5F) 68 (59–89) Autopsy
Severe OA 9 (6M, 3F) 77 (39–85) Total hip arthroplasty
Table II
Immunohistochemical scoring
Score Cell score (0–4) Matrix score (0–2)
0 All cells negative No staining
1 Less cells negative Weak, localized
staining
2 Equal number of negative and
positive cells
Extensive staining
3 More cells positive
4 All cells positive
Table III
Histopathological features of normal articular cartilage and articular cartilage with mild and severe OA
Structure Cells
Normal Fibrillation Sup. fiss. Middle fissure Deep fissure Normal Clones
Normal
Central (8) 8 3 5
Peripheral (8) 7 1 5 3
Mild OA
Central (10) 7 2 1 3 7
Peripheral (10) 10 3 7
Severe OA
Central (9) 3 3 2 1 2 7
Peripheral (4) 1 2 1 1 3
Sup. fiss., superficial fissure. Numbers refer to number of cases displaying each feature.
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Fig. 1. Histology of normal articular cartilage and articular cartilage with mild and severe OA. SFH stainings. (A) Normal articular cartilage
(magnification approximately ×40). (B) Articular cartilage with mild OA showing mild fibrillation at the entire surface and loss of safranin-O
staining (magnification approximately ×20). (C) Articular cartilage with severe OA showing more advanced fibrillation, a fissure through the
superficial zone, but no loss of safranin-O staining intensity (magnification approximately ×20).
peroxidase-conjugated streptavidin was added and incu-
bated for 25 min. After washing, antibody binding was
visualized by adding a buffered solution of H2O2 and
3-amino-9-ethyl-carbazole for 15 min, yielding a crispy red
end-product at the sites of the antigen. Specimens were
then washed with tap water and counterstained with
Maier’s haematoxylin.
PROCEDURE CONTROLS
Both omission of the primary antibody and application of
non-immune mouse immunoglobulins in the same protein
concentration were used as negative controls. To test for
demasking of TN antigens, the specimens were either
pretreated with 0.1% trypsin for 30 s at 37°C or a combi-
nation of hyaluronidase (2 mg/ml) and collagenase (10 mg/
ml) for 5 min at 37°C before the standard immunostaining,
but no demasking effect was observed (data not shown).
Skin was used as the external positive control tissue.
EVALUATION OF HISTO- AND IMMUNOHISTOCHEMICAL STAININGS
Grading of both histo- and immunohistochemical
stainings was performed by two blinded observers in
companion, and the scores were agreed upon.
SFH stainings evaluated the structure of cartilage and
the cells. For structure, five classes were employed: nor-
mal, fibrillation, fissure involving the superficial zone only,
fissure into the middle zone, and fissure into the deep zone.
Cells were evaluated for the presence of clones. A clone
was defined as a clustering of at least three cells located in
the same rounded lacuna.
IHC stained preparations were evaluated as described
by Ostergaard and Salter9. In brief, cartilage sections were
divided into the superficial (upper 1/4), deep (1/4 of section
above tidemark), and middle (1/2 in between) zones. Each
zone received a cellular score from 0 to 4 and a matrix
score in the peri- and intercellular compartments from 0 to
2 as shown in Table II. Cellular staining represents intra-
cellular as well as membrane associated staining, as these
cannot be definitely distinguished from the methods used.
The grading system used does not directly reflect the actual
concentration of TN, but rather the extension of staining.
Quantification of non-fluorescent immunohistochemical
stainings is not sufficiently reproducible9.
STATISTICS
Comparison of the scores of central and peripheral
biopsies from the same subject was performed by Wilcoxon
matched-pairs signed rank test in normal cartilage and
cartilage with mild and severe OA. Comparison of scores of
normal cartilage and cartilage with mild and severe OA at
both the central and peripheral sampling sites was per-
formed by Mann–Whitney rank sum test. P values less than
0.05 were considered significant.
ETHICS
The study was approved by a regional ethics committee




Macroscopically normal cartilage (grade 0) showed only
occasional structural defects. Cartilage sampled from the
lesional central sampling site from femoral heads with mild
OA (grades 1 and 2) showed histological defects in all
cases ranging from fibrillation to fissures into the middle
zone. All cartilage biopsies from femoral heads with severe
OA (grades 3 and 4) showed structural defects ranging
from fibrillation to fissures into the deep zone. In 65% of all
sections clones were present. There was a tendency for the
clones to be increased in femoral heads with mild or severe
OA (Table III and Fig. 1).
Table IV
The expression of TN in all zones and compartments of central and peripheral biopsies of normal articular cartilage and articular cartilage
with mild and severe OA
Central Peripheral
Cell score (0–4) Matrix score(0–2) Cell score (0–4) Matrix score (0–2)
Pericellular Intercellular Pericellular Intercellular
Normal
Superficial 0.5 0 0 2 0.5 0
Middle 0 0 0 0 0 0
Deep 0 0 0 0 0 0
Mild OA
Superficial 3.5* 1* 1* 1 0 0
Middle 1 0 0 0 0 0
Deep 0 0 0 0 0 0
Severe OA
Superficial 4 2 2 4 1.5 1.5
Middle 2 1 0 2 1 0.5
Deep 0.5 0 0 1 0.5 0.5
Values are given as medians. In each person, the central biopsy is compared with the corresponding peripheral biopsy for each zone and
compartment by the Wilcoxon matched-pairs signed ranks test. In the superficial zone of cartilage with mild OA, there is a significantly
increased expression in the lesional, central biopsies (*, cellular: P0.031, pericellular: P0.008, intercellular: P0.016). See Table II for
denotation of scores.
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Fig. 2 (A) and (B)
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Fig. 2 (C), (D) and (E)
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TENASCIN EXPRESSION IN CENTRAL VERSUS PERIPHERAL
ARTICULAR CARTILAGE
In macroscopically normal cartilage, the highest level of
expression of TN was located in the peripheral biopsies.
Only half of the central biopsies showed cellular staining
and only one biopsy showed matrix staining. Only one
central biopsy showed TN staining in the middle or deep
zone. Almost all the peripheral biopsies showed TN stain-
ing in the cellular compartment and half of the biopsies
showed matrix staining in the superficial zone. In the middle
and deep zones almost half the peripheral biopsies showed
TN staining in all compartments; these differences did not
achieve statistical significance (Table IV).
In mild OA, the superficial zone of lesional, central
cartilage shows a significantly increased TN expression
compared with the peripheral biopsies. In the majority of
the central biopsies the cellular TN staining spread into the
middle zone, whereas in the peripheral biopsies this was
only occasionally the case. Matrix staining was rarely
present in the middle or deep zones (Table IV).
Cartilage from femoral heads with severe OA showed
very high levels of TN in the superficial zone of central as
well as peripheral biopsies. Staining was present in all
compartments in the middle zone of almost all biopsies and
in the deep zone of half of the biopsies of both central and
peripheral cartilage. Regarding cartilage with severe OA no
difference between central and peripheral biopsies is
present (Table IV and Fig. 2).
COMPARING TENASCIN EXPRESSION IN CENTRAL CARTILAGE
FROM NORMAL JOINTS AND FROM JOINTS WITH MILD AND
SEVERE OA
In cartilage with mild or severe OA, the staining of TN in
the superficial zone was significantly increased in all com-
partments (Fig 4). Cartilage with severe OA showed the
highest level of staining, but this was not significantly
different from the level in mild OA (Table IV).
In the middle zone, the expression of TN was signifi-
cantly increased in the cellular and pericellular compart-
ments in cartilage with severe OA when compared with
normal cartilage (P<0.05). Cartilage with mild and severe
OA only differed significantly in this zone in the pericellular
compartment, whereas no significant difference was
present between normal cartilage and cartilage with mild
OA (Table IV).
In the deep zone, the expression of TN was highest in
cartilage with severe OA, where half the sections showed
cellular staining. Staining was only occasionally present in
the deep zone of normal cartilage or cartilage with mild
OA. This difference did not achieve statistical significance
(Table IV).
COMPARING TENASCIN EXPRESSION IN PERIPHERAL CARTILAGE
FROM NORMAL JOINTS AND FROM JOINTS WITH MILD AND
SEVERE OA
In the superficial zone, there was a significantly in-
creased expression of TN in cartilage with severe OA in all
compartments when compared with mild OA (P<0.05) (Fig.
5). There was no significant difference between normal
cartilage and cartilage with mild OA, but significant differ-
ence was observed only in the intercellular compartment
when comparing normal cartilage and cartilage with severe
OA (P0.008).
In the middle and deep zones no statistically significant
difference between any of the three groups was present;
however, the biopsies with severe OA showed a tendency
towards increased expression of TN (Table IV).
Discussion
This study shows that the expression of TN is focally
increased in human articular cartilage with mild OA,
whereas cartilage with severe OA shows increased expres-
sion through all zones and compartments at both the
central and the peripheral sampling sites. Consideration of
TN as a molecular marker of OA supports the idea of mild
OA being a focal condition regarding both depth and width,
whereas severe OA extends to all zones and areas of the
femoral head. To our knowledge, this is the first study to
describe the topographic differences in the expression of a
potential molecular marker of OA in human cartilage with
mild OA compared with normal cartilage and with cartilage
with severe OA.
The individuals with femoral heads with mild OA
reported no symptoms of joint pain in their case books.
One could then speculate that the cartilage degradation
could be attributed to age-related degenerative changes.
But the central sampling sites used in this study corre-
spond to load bearing areas of the femoral head1 and are
thus very likely to represent functionally important and
clinically significant areas, even though this cannot be
documented.
The increasing presence of TN with increasing severity
of OA in our study corresponds to what was found in a
rabbit model of moderate and severe OA7. In the rabbit
model, TN staining appears to spread from the middle and
deep zones to the superficial zone with increasing severity
of OA. In our and in other studies on humans the strongest
staining is reported pericellular in the superficial zone in
normal cartilage as well as in cartilage with OA4. With
increasing severity of OA, TN staining appears to extend to
the deeper zones4. This is in accordance with a study of the
progression of OA, wherein the extent of denaturation of
collagen type II fibrils in human femoral condylar cartilage
Fig. 2. TN stainings of normal articular cartilage and articular cartilage with mild and severe OA. (A) Normal articular cartilage from the central
sampling site. Only occasional positive chondrocytes are seen in the superficial zone but a discrete line of TN staining is present in the
uppermost part of the superficial zone indicating that the source of TN is primarily the synovial fluid (magnification approximately ×10). (B)
Normal articular cartilage containing a cluster of chondrocytes showing the cellular localization of TN in one chondrocyte (magnification
approximately ×40). (C) Central articular cartilage with mild OA showing extensive staining of the fibrillated areas. Underneath are positive
chondrocytes with a discrete zone of TN in the pericellular compartment superficial to the chondrocytes (magnification approximately ×10).
(D) Peripheral articular cartilage from a femoral head with mild OA. Only a few chondrocytes are positive (magnification approximately ×10).
(E) Articular cartilage with severe OA showing diffuse staining in the peri- and intercellular compartments and positive chondrocytes in the
middle and deep zones (magnification approximately ×20).
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Fig. 3. Negative control stainings with non-immune mouse immunoglobulins. (A) Normal articular cartilage. (B) Articular cartilage with mild
OA. (C) Articular cartilage with severe OA. No staining is present. Magnification approximately ×10.
224 K. Veje et al.: Expression of TN in mild and severe OA
was studied12. This study therefore proposed that OA
originates around chondrocytes in the superficial zone and
propagates to the deeper zones in later stages of the
disease. The rabbit model7 describes secondary OA in the
knee joint due to meniscectomy, whereas our study en-
gages primary OA in the hip joint. This could also explain
the differences in zonal distribution of TN between our
study and the rabbit model.
In accordance with our findings, Chevalier et al.3
reported increased expression of TN around clefts and
Fig. 4. TN staining in the superficial zone of normal cartilage and cartilage from femoral heads with mild and severe OA at the central
sampling site. Values are given as medians with the upper and lower bracket representing the 75 and the 25 percentile, respectively. The
expression of TN in normal articular cartilage differs significantly from articular cartilage with mild OA (Mann–Whitney rank sum test, cellular:
P0.001, pericellular: P0.005, and intercellular: P0.004) and severe OA (cellular: P<0.001, pericellular: P0.001, and intercellular:
P<0.001), whereas no significant difference was present when comparing articular cartilage with mild and severe OA. See Table II for
denotation of scores.
Fig. 5. TN staining in the superficial zone of peripheral localized normal cartilage and cartilage with mild and severe OA. Values are given
as medians with the upper and lower bracket representing the 75 and the 25 percentile, respectively. The expression of TN is significantly
increased in the cellular compartment in articular cartilage with severe OA when compared with corresponding mild OA (Mann–Whitney rank
sum test, P0.019). There is no difference between normal articular cartilage and articular cartilage with mild OA. See Table II for denotation
of scores.
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fibrillation in a study of human femoral head cartilage
with severe OA, suggesting a role for TN in the repair
of cartilage.
In a study of human synovial fluid from knees of 65
patients with pain and joint impairment, TN proved to be the
most promising molecular marker of cartilage degradation
compared with cartilage oligomeric matrix proteins, YKL-40
and MMP-1, -3, and -135. TN levels were only correlated to
the most severe arthroscopic grades of OA, though. As
shown in our study, the expression of TN in cartilage with
mild OA is only increased localized to lesional areas while
peripheral, non-lesional cartilage displays levels of TN
similar to or even less than macroscopical and histological
normal cartilage. This might account for the lack of corre-
lation between levels of TN and the mild grades of OA
found at arthroscopy. Thus, more sensitive TN assays
might be able to detect elevated TN levels in synovium from
joints with mild OA.
The Arg-Gly-Asp-sequence in TN binds Fn13 and integrin
αVβ314. Other TN ligands are syndecan15, integrin α2β114,
and annexin II13. The integrin subunits αV and β1 are
present in normal human articular cartilage and in cartilage
with severe OA, the α2 subunit has been localized in
cartilage with severe OA only, whereas the β3 subunit is
localized neither in the normal cartilage nor in cartilage with
severe OA16.
High levels of Fn (especially Fn fragments) induce a
catabolic response through release of proinflammatory
cytokines, catabolic enzymes and proteoglycan depletion,
whereas low levels induce enhanced rates of proteoglycan
synthesis17. Enhanced levels of TN might counteract the
chondrolytic effects of the high levels of Fn found in OA4.
One would then suspect a co-localization of Fn and TN in
cartilage with OA. Increased staining of Fn as well as TN is
indeed found in areas of fibrillated rabbit cartilage7. In
central human articular cartilage with severe OA, staining
of Fn is increased in the superficial layer and extends
into the middle zone (unpublished observation), like the
expression of TN in our study.
The source of TN in articular cartilage is still unclear. In
this study, cellular staining was present in combination with
strong pericellular staining. Occasionally, single chondro-
cytes contained staining in what resembles the intracellular
compartment only [Fig. 2(B)]. This cellular staining of TN is
not likely to be unspecific due to dying cells, as this was not
found in the negative controls [Fig. 3(A–C)]. In most sec-
tions of fibrillated cartilage from femoral heads with mild
OA, an area of cartilage superficial to the chondrocytes was
strongly positive, suggesting that chondrocyte-derived TN
is secreted and directed towards the articulating surface
[Fig. 2(C)]. IL-1β upregulates the expression of TN in the
pericellular compartment18 and bovine articular chondro-
cytes synthesize TN19. On the other hand, occasional
staining of the extracellular matrix was present in the
uppermost part of the superficial zone with only few
chondrocytes positive for TN [Fig. 2(A)]. This suggests that
TN may be derived from both the chondrocytes and the
synovium.
In normal cartilage and cartilage with severe OA no
topographical variation was observed in this study,
whereas central and peripheral cartilage with mild OA
differed significantly regarding the expression of TN. This
underlines the importance of including topography and
macroscopical description of the sampling site, as random
sampling from a femoral head with mild OA could result
in false conclusions. This is supported by the knowledge
that several molecules are known to be expressed with
topographic (e.g. YKL-4020 and collagen type VI21) or zonal
variation (e.g. integrin αV16 and CD4411).
The monoclonal antibody used in this study recognizes
all variants of TN so that the differential expression of the
variants cannot be determined. As the TN variants possess
different functions (i.e. regarding the binding of Fn)13
caution is needed when deducing the consequences of our
results for cartilage metabolism.
As quantitative evaluation of IHC stainings is not ad-
equately reproducible22, a rather crude evaluation was
used in this study. Minor differences may be missed, but
using this method of evaluation the results are expected to
be more reproducible.
The small sample size of this study (n4) is very likely
the reason why the obviously increased expression of TN in
peripheral biopsies from femoral heads with severe OA
did not achieve statistical significance in more than one
compartment.
In conclusion, we have detailed the increased expression
of TN in load bearing areas of human cartilage with mild OA
to be accumulated in areas showing structural damage and
to be primarily localized in the superficial zone. This sug-
gests that TN is involved in the early events of OA.
Cartilage with severe OA expresses increased levels of TN
in all zones and compartments and the increased expres-
sion of TN includes central as well as peripheral areas.
Since TN is considered to be a molecular marker for OA,
this proposes mild OA to be a localized disorder, whereas
severe OA is generalized. Extreme caution is necessary for
sampling of articular cartilage, especially from joints with
mild OA.
Future research should identify metabolic or biomechani-
cal factors responsible for the enhanced expression of TN.
In addition, a more accurate role for TN in articular cartilage
should be determined, especially considering the functions
of the various TN isoforms as antagonists for Fn in vivo.
Acknowledgements
We gratefully acknowledge Dr V. Andersen for critical
review of the manuscript. The skillful technical assistance
of V. Weibull is highly appreciated.
References
1. Byers PD, Pringle J, Oztop F, Fernley HN, Brown MA,
Davison W. Observations on osteoarthrosis of the
hip. Semin Arthritis Rheum 1977;6(3):277–303.
2. Chiquet-Ehrismann R, Hagios C, Schenk S. The com-
plexity in regulating the expression of tenascins.
Bioessays 1995;17(10):873–8.
3. Chevalier X, Groult N, Larget Piet B, Zardi L,
Hornebeck W. Tenascin distribution in articular carti-
lage from normal subjects and from patients with
osteoarthritis and rheumatoid arthritis. Arthritis
Rheum 1994;37(7):1013–22.
4. Salter DM. Tenascin is increased in cartilage and
synovium from arthritic knees. Br J Rheumatol 1993;
32(9):780–6.
5. Schmidt-Rohlfing B, Gavenis K, Kippels M, Schneider
U. New potential markers for cartilage degradation of
the knee joint. Scand J Rheumatol 2002;31(3):
151–7.
6. Cutolo M. Tenascin and arthritis. Br J Rheumatol 1994;
33(2):197–8.
226 K. Veje et al.: Expression of TN in mild and severe OA
7. Pfander D, Rahmanzadeh R, Scheller EE. Presence
and distribution of collagen II, collagen I, fibronectin,
and tenascin in rabbit normal and osteoarthritic
cartilage. J Rheumatol 1999;26(2):386–94.
8. Meachim G, Collins DH. Cell counts of normal and
osteo-arthrotic articular cartilage in relation to the
uptake of sulphate (35SO4) in vitro. Ann Rheum Dis
1962;21(45):45–9.
9. Ostergaard K, Salter DM. Immunohistochemistry in the
study of normal and osteoarthritic articular cartilage.
Prog Histochem Cytochem 1998;33(2):93–165.
10. Hyllested JL, Veje K, Ostergaard K. Histochemical
studies of the extracellular matrix of human articu-
lar cartilage—a review. Osteoarthritis Cartilage 2002;
10(5):333–43.
11. Ostergaard K, Salter DM, Andersen CB, Petersen J,
Bendtzen K. CD44 expression is up-regulated in the
deep zone of osteoarthritic cartilage from human
femoral heads. Histopathology 1997;31(5):451–9.
12. Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne
R, Poole AR. Damage to type II collagen in aging and
osteoarthritis starts at the articular surface, originates
around chondrocytes, and extends into the carti-
lage with progressive degeneration. J Clin Invest
1995;96(6):2859–69.
13. Chung CY, Zardi L, Erickson HP. Binding of tenascin-C
to soluble fibronectin and matrix fibrils. J Biol Chem
1995;270(48):29012–7.
14. Tremble P, Chiquet Ehrismann R, Werb Z. The extra-
cellular matrix ligands fibronectin and tenascin col-
laborate in regulating collagenase gene expression in
fibroblasts. Mol Biol Cell 1994;5(4):439–53.
15. Hofer U, Chiquet-Ehrismann R. Tenascin variants: lig-
ands and expression. Prog Clin Biol Res 1993;
383B:455–64.
16. Ostergaard K, Salter DM, Petersen J, Bendtzen K,
Hvolris J, Andersen CB. Expression of alpha and
beta subunits of the integrin superfamily in articular
cartilage from macroscopically normal and osteo-
arthritic human femoral heads. Ann Rheum Dis 1998;
57(5):303–8.
17. Homandberg GA, Wen C. Exposure of cartilage to a
fibronectin fragment amplifies catabolic processes
while also enhancing anabolic processes to limit
damage. J Orthop Res 1998;16(2):237–46.
18. Chevalier X, Claudepierre P, Groult N, Godeau GJ.
Influence of interleukin 1 beta on tenascin distribution
in human normal and osteoarthritic cartilage: a quan-
titative immunohistochemical study. Ann Rheum Dis
1996;55(10):772–5.
19. Savarese JJ, Erickson H, Scully SP. Articular chondro-
cyte tenascin-C production and assembly into de
novo extracellular matrix. J Orthop Res 1996;14(2):
273–81.
20. Volck B, Ostergaard K, Johansen JS, Garbarsch C,
Price PA. The distribution of YKL-40 in osteoarthritic
and normal human articular cartilage. Scand J
Rheumatol 1999;28:171–9.
21. Pullig O, Weseloh G, Swoboda B. Expression of
type VI collagen in normal and osteoarth-
ritic human cartilage. Osteoarthritis Cartilage
1999;7(2):191–202.
22. Hyllested JL, Veje K, Ostergaard K. Reproducibility
of immunohistochemical scoring. Histopathol (Sub-
mitted for publication).
Osteoarthritis and Cartilage Vol. 11, No. 3 227
